| Financial Year |
March 31 2023 |
| Monetary Funds |
354,517,107.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
44,336,333.58 |
| Advances to Suppliers |
21,485,643.17 |
| Other Receivables |
230,136,665.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,465,011,828.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
32,618,567.42 |
| Other Current Assets |
59,306,892.13 |
| Total Current Assets |
3,207,413,038.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
205,231,116.46 |
| Long-term Equity Investment |
282,517,815.75 |
| Investment Properties |
8,088,233,076.44 |
| Fixed Assetes |
1,457,543,570.51 |
| Under-construction Projects |
5,065,136.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,197,659.15 |
| R&D expenses |
-- |
| Goodwill |
4,426,396.28 |
| Long-Term Deferred and Prepaid Expenses |
269,140,787.43 |
| Deferred Income Tax Assets |
265,283,754.97 |
| Other Non-Current Assets |
240,931,797.16 |
| Sub-Total of Non-Current Assets |
11,471,161,016.46 |
| Total Assets |
14,678,574,054.59 |
| Short-Term Loans |
1,100,546,857.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,003,717.52 |
| Accounts Payable |
904,342,825.38 |
| Accounts Received In Advance |
30,948,127.51 |
| Employee Compensation Payable |
12,523,950.26 |
| Taxes Payable |
196,968,754.81 |
| Interest Payable |
-- |
| Dividend Payable |
1,165,047.89 |
| Other payables |
1,206,012,727.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,342,370,197.32 |
| Other Current Liabilities |
293,079,539.95 |
| Sub-Total of Current Liabilities |
5,582,983,900.79 |
| Long-term Loans |
3,152,643,716.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
557,919,983.87 |
| Other Non-Current Liabilities |
21,899,620.86 |
| Sub-Total of Non-Current Liabilities |
4,914,102,108.38 |
| Total Liabilities |
10,497,086,009.17 |
| Paid-In Capital(Or Share Stock) |
869,846,246.00 |
| Capital Surplus |
3,520,962.56 |
| Surplus Reserve |
203,600,330.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,362,100,584.53 |
| Minority Stockholder's Interest |
651,058,696.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,530,429,348.50 |
| Owner's Equity（Stockholder's Equity） |
4,181,488,045.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,678,574,054.59 |
